Skip to main content
Premium Trial:

Request an Annual Quote

IDT Acquires Oligo Synthesis Firm ValueGene

NEW YORK (GenomeWeb) – Integrated DNA Technologies announced it has acquired San Diego-based oligonucleotide synthesis firm ValueGene.

ValueGene offers custom synthetic DNA and RNA oligos as well as polyacrylamide gel electrophoresis and high-performance liquid chromatography purification and modification services.

Financial and other terms of the deal were not disclosed.

"ValueGene is well known in San Diego and Los Angeles," Dan Dernbach, IDT's general manager of West Coast operations, said in a statement. "We welcome the opportunity to serve ValueGene's customers and provide them the benefit of our portfolio of reagents for genomics research to support their important discoveries."

Coralville, Iowa-based IDT offers a range of synthetic nucleic acids for molecular biology. The deal is the latest acquisition for the firm and the first since December 2015, when the firm bought the oligonucleotide business of Singapore's AITbiotech. Recently, the firm acquired rights to sell CRISPR/Cas9 reagents in a non-exclusive deal with Caribou Biosciences.